Patents by Inventor Ophelia Qiping YIN

Ophelia Qiping YIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATION
    Publication number: 20230338283
    Abstract: Disclosed is a pharmaceutical mini-tablet comprising mitapivat or a pharmaceutically acceptable salt thereof, and in a particular embodiment comprising a mitapivat sulfate salt, and one or more inactive ingredients selected from a filler, disintegrant, lubricant, binder, and diluent.
    Type: Application
    Filed: September 24, 2021
    Publication date: October 26, 2023
    Inventors: Cheuk-Yui Leung, Eric Simone, Ophelia Qiping Yin
  • PEXIDARTINIB RISK EVALUATION AND MITIGATION STRATEGY (REMS)
    Publication number: 20220036993
    Abstract: The present disclosure relates generally to methods for using pexidartinib and related Risk Evaluation and Mitigation Strategy (REMS), while reducing the occurrence of hepatotoxic adverse events.
    Type: Application
    Filed: July 30, 2021
    Publication date: February 3, 2022
    Inventors: Dale Edward SHUSTER, Hamim ZAHIR, Ophelia Qiping YIN, Leonidas Daniel DROGARIS, Vikram Jeet DEV, Laurie DELEVE, James Hendricks LEWIS
  • METHODS FOR ADMINISTERING PEXIDARTINIB
    Publication number: 20220034871
    Abstract: The present disclosure relates generally to methods for using pexidartinib and related Risk Evaluation and Mitigation Strategy (REMS), while reducing the occurrence of hepatotoxic adverse events.
    Type: Application
    Filed: July 30, 2021
    Publication date: February 3, 2022
    Inventors: Dale Edward SHUSTER, Hamim ZAHIR, Ophelia Qiping YIN, Leonidas Daniel DROGARIS, Vikram Jeet DEV, Laurie DELEVE, James Hendricks LEWIS